MEDIA

Latest News

Revance is a biotechnology company focused on innovative aesthetic and therapeutic offerings, as well as financial technology services for aesthetic practices.

18 May 2021

Business Insider: See the 29 fastest-growing biotech companies, which hired hundreds of new workers in 2020 and grew by at least 50%

27 April 2021

Enrollment underway in Revance Therapeutics’ late-stage DaxibotulinumtoxinA study

27 April 2021

Experts Call These the Most Cutting-Edge Aesthetic Treatments

20 April 2021

Bringing Botulinum Toxin Trials Closer to Real-Life Conditions

16 April 2021

The Shape 2021 Skin Awards Will Give You the Glow-Up This Year Needs

01 March 2021

Which Filler Is Right for You? Docs Say, Consider These 6 Things

06 February 2021

2020 Aged Us All, But Hollywood’s Fighting Back With These New Beauty Go-Tos

29 January 2021

Revance: ePosters Showcase Data for DaxibotulinumtoxinA and RHA Line at Maui Derm

21 January 2021

8 Filler Updates Happening Right Now

07 January 2021

Dermatology Times: DAXI demonstrates positive results in phase 2 study

21 December 2020

For Upper Facial Lines, DaxibotulinumtoxinA Succeeds in Phase 2

17 December 2020

Revance Therapeutics Inc – Treatment With DaxibotulinumtoxinA For Injection Was Well Tolerated Across Upper Facial Regions